I was asked to do a presentation on the following paper:

Juratli, Mazen & Menyaev, Yulian & Sarimollaoglu, Mustafa & Siegel, Eric & Nedosekin, Dmitry & Suen, James & Melerzanov, Alexander & Juratli, Tareq & Galanzha, Ekaterina & Zharov, Vladimir. (2016). Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry. PloS one. 11. e0156269. 10.1371/journal.pone.0156269.

In the introduction, it says something like this: "However, application of the PA technique to the real-time monitoring of embolus dynamics during a medical intervention in large vessels is challenging. The main goal in this paper is to demonstrate that the in vivo PAFC can rapidly detect emboli triggered by melanoma and (...)"

- My interpretation of this is that, for some reason, PA isn't enough so it must be used together with flow cytometry. I would like to know why and what is the difference.

Similar questions and discussions